22nd Annual Conference
Frontiers in Diabetes Research
Obesity, Diabetes & COVID 19: Elucidating Biodirectional Links
Saturday, November 21, 2020 via Zoom
10:00AM - 3:00PM EST
PROGRAM DESCRIPTION & OBJECTIVES
This complimentary virtual half-day program is designed for research scientists, clinicians, and students with an interest in diabetes and obesity. Specifically, this conference will focus on recent clinical and basic insights regarding SARS-CoV2 infection. Particular emphasis will be placed on the potential metabolic/genetic and demographic links to susceptibility and clinical outcomes in patients with obesity and pre-existing diabetes. Additional areas of focus will include novel treatment paradigms for diabetes in the COVID-19 era, and a look forward towards novel antiviral therapies.
At the conclusion of this activity, participants will be better able to:
- Review epidemiology, pathogenesis, and current/future treatment paradigms for COVID-19.
- Discuss obesity and diabetes as risk factors for SARS-CoV2-related patient outcomes.
- Discuss management of diabetes and dysmetabolism in patients with COVID-19.
AMA CREDIT DESIGNATION STATEMENT
The Columbia University Vagelos College of Physicians and Surgeons designates this live activity for a maximum of 4.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
For additional information contact email@example.com